← All Topics / ade

FDA ADE reports for n-butylscopolaminium bromide — total reports, species & reaction breakdown

ade_n_butylscopolaminium_bromide_adverse_events

ade 200 tok en 2026-08-16

n-butylscopolaminium bromide — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-08-16. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. "n-butylscopolaminium bromide" is a name as filed in the drug active-ingredient field of these reports (may be a generic ingredient or a product/brand name as reported).

Total reports

n-butylscopolaminium bromide: 94

Reports by species (top entries)

  • Horse 74
  • Human 2
  • Donkey 1

Top reported reactions (VEDDRA terms, top entries)

  • Death by euthanasia 24
  • Colic 14
  • Other abnormal test result NOS 13
  • Death 11
  • Vials, Damaged 11
  • Lack of efficacy - NOS 9
  • Ataxia 7
  • Recumbency 6
  • Abnormal ultrasound finding 5
  • Anorexia 5

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-08-16_b1.json (openFDA animalandveterinary/event.json, pulled 2026-08-16).

Sources

FDA ADE reports for n-butylscopolaminium bromide — total reports, species & reaction breakdown
Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports
US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-08-16

Verification file: pdf-raw/ade/ade_active_ingredients_2026-08-16_b1.json

Link points to the issuing authority's site; a direct document link is still being verified.